Cargando…

Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report

With the modern technological developments in the diagnosis and treatment of cancer, the survival rate of cancer patients has increased. On the other hand, the incidence of multiple primary tumors is increasing annually. Lynch syndrome (LS), an autosomal dominant disorder with germline mutations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jing, Huang, Ting, Lin, Xianlei, Zhang, Yu, Yang, Xuefei, Huang, Ling, Ye, Zhifeng, Ren, Xingchang, Teng, Lisong, Li, Jun, Kong, Mei, Lian, Liyan, Lu, Jinhua, Zhong, Yazhen, Lin, Zechen, Xu, Ming, Chen, Yin, Lin, Shengyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128403/
https://www.ncbi.nlm.nih.gov/pubmed/35619908
http://dx.doi.org/10.3389/fonc.2022.896024
_version_ 1784712553452011520
author Jiang, Jing
Huang, Ting
Lin, Xianlei
Zhang, Yu
Yang, Xuefei
Huang, Ling
Ye, Zhifeng
Ren, Xingchang
Teng, Lisong
Li, Jun
Kong, Mei
Lian, Liyan
Lu, Jinhua
Zhong, Yazhen
Lin, Zechen
Xu, Ming
Chen, Yin
Lin, Shengyou
author_facet Jiang, Jing
Huang, Ting
Lin, Xianlei
Zhang, Yu
Yang, Xuefei
Huang, Ling
Ye, Zhifeng
Ren, Xingchang
Teng, Lisong
Li, Jun
Kong, Mei
Lian, Liyan
Lu, Jinhua
Zhong, Yazhen
Lin, Zechen
Xu, Ming
Chen, Yin
Lin, Shengyou
author_sort Jiang, Jing
collection PubMed
description With the modern technological developments in the diagnosis and treatment of cancer, the survival rate of cancer patients has increased. On the other hand, the incidence of multiple primary tumors is increasing annually. Lynch syndrome (LS), an autosomal dominant disorder with germline mutations in DNA mismatch repair genes, increases the risk of cancer in patients carrying those mutations. In this report, we present an extremely rare case of an 81-year-old male patient with eight primary malignancies and LS. The patient is still alive having survived for more than 41 years since the initial discovery of the first tumor. The eighth and most recently diagnosed primary cancer was a malignant peripheral nerve sheath tumor. Although there have been numerous reports of malignancies in LS, malignant peripheral nerve sheath tumors have not been reported previously with LS. Here, we report, to the best of our knowledge, the first case of a malignant peripheral nerve sheath tumor with LS.
format Online
Article
Text
id pubmed-9128403
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91284032022-05-25 Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report Jiang, Jing Huang, Ting Lin, Xianlei Zhang, Yu Yang, Xuefei Huang, Ling Ye, Zhifeng Ren, Xingchang Teng, Lisong Li, Jun Kong, Mei Lian, Liyan Lu, Jinhua Zhong, Yazhen Lin, Zechen Xu, Ming Chen, Yin Lin, Shengyou Front Oncol Oncology With the modern technological developments in the diagnosis and treatment of cancer, the survival rate of cancer patients has increased. On the other hand, the incidence of multiple primary tumors is increasing annually. Lynch syndrome (LS), an autosomal dominant disorder with germline mutations in DNA mismatch repair genes, increases the risk of cancer in patients carrying those mutations. In this report, we present an extremely rare case of an 81-year-old male patient with eight primary malignancies and LS. The patient is still alive having survived for more than 41 years since the initial discovery of the first tumor. The eighth and most recently diagnosed primary cancer was a malignant peripheral nerve sheath tumor. Although there have been numerous reports of malignancies in LS, malignant peripheral nerve sheath tumors have not been reported previously with LS. Here, we report, to the best of our knowledge, the first case of a malignant peripheral nerve sheath tumor with LS. Frontiers Media S.A. 2022-05-10 /pmc/articles/PMC9128403/ /pubmed/35619908 http://dx.doi.org/10.3389/fonc.2022.896024 Text en Copyright © 2022 Jiang, Huang, Lin, Zhang, Yang, Huang, Ye, Ren, Teng, Li, Kong, Lian, Lu, Zhong, Lin, Xu, Chen and Lin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Jiang, Jing
Huang, Ting
Lin, Xianlei
Zhang, Yu
Yang, Xuefei
Huang, Ling
Ye, Zhifeng
Ren, Xingchang
Teng, Lisong
Li, Jun
Kong, Mei
Lian, Liyan
Lu, Jinhua
Zhong, Yazhen
Lin, Zechen
Xu, Ming
Chen, Yin
Lin, Shengyou
Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report
title Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report
title_full Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report
title_fullStr Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report
title_full_unstemmed Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report
title_short Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report
title_sort long-term survival of a lynch syndrome patient with eight primary tumors: a case report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128403/
https://www.ncbi.nlm.nih.gov/pubmed/35619908
http://dx.doi.org/10.3389/fonc.2022.896024
work_keys_str_mv AT jiangjing longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT huangting longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT linxianlei longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT zhangyu longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT yangxuefei longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT huangling longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT yezhifeng longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT renxingchang longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT tenglisong longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT lijun longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT kongmei longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT lianliyan longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT lujinhua longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT zhongyazhen longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT linzechen longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT xuming longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT chenyin longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport
AT linshengyou longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport